Shukra Pharmaceuticals Ltd. - Research Center
524632 SHUKRAPHAR Group (XT) BSE data
Add to watchlist
| Results |
Half yearly
|
| Statement | |
| More |
Half yearly results in brief
(Rs crore)
| Sep ' 20 | Mar ' 20 | Sep ' 19 | Sep ' 18 | Sep ' 17 | |
|---|---|---|---|---|---|
| Sales | 2.78 | 9.32 | 2.53 | 1.91 | 1.07 |
| Operating profit | 0.60 | 2.41 | -0.87 | 0.62 | 0.26 |
| Interest | - | - | - | - | - |
| Gross profit | 0.84 | 1.02 | 0.53 | 0.65 | 0.31 |
| EPS (Rs) | 0.71 | 0.05 | 0.18 | 0.33 | 0.50 |
Half yearly
results in details
| Sep ' 20 | Mar ' 20 | Sep ' 19 | Sep ' 18 | Sep ' 17 | |
|---|---|---|---|---|---|
| Other income | 0.24 | -1.39 | 1.40 | 0.04 | 0.05 |
| Stock adjustment | -0.68 | -0.18 | -0.08 | -0.10 | -0.17 |
| Raw material | 0.42 | 1.90 | 1.43 | 0.17 | 0.12 |
| Power and fuel | - | - | - | - | - |
| Employee expenses | 1.49 | 2.73 | 1.67 | 0.91 | 0.57 |
| Excise | - | - | - | - | - |
| Admin and selling expenses | - | - | - | - | - |
| Research and development expenses | - | - | - | - | - |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 0.96 | 2.45 | 0.38 | 0.31 | 0.29 |
| Provisions made | - | - | - | - | - |
| Depreciation | 0.72 | 0.97 | 0.50 | 0.37 | 0.20 |
| Taxation | - | 0.14 | - | 0.18 | 0.03 |
| Net profit / loss | 0.11 | 0.01 | 0.03 | 0.05 | 0.08 |
| Extra ordinary item | - | 0.10 | - | -0.05 | - |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 1.57 | 1.57 | 1.57 | 1.57 | 1.57 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | - | - | - | - | - |
| Agg.of non promotoholding (%) | - | - | - | - | - |
| OPM (%) | 21.53 | 25.84 | -34.27 | 32.33 | 24.79 |
| GPM (%) | 27.62 | 12.81 | 13.55 | 33.58 | 27.96 |
| NPM (%) | 3.67 | 0.10 | 0.70 | 2.62 | 7.02 |
Mutual Fund Selector
Find the fund that is right for you
© 2020 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis